Anzeige
Mehr »
Login
Sonntag, 16.05.2021 Börsentäglich über 12.000 News von 658 internationalen Medien
Analysten vergeben Bestnoten und hohe Kursziele bis zu 13,50! Das ist der Grund!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1H65A ISIN: NL0010391025 Ticker-Symbol: PHGN 
Tradegate
14.05.21
17:07 Uhr
1,004 Euro
+0,018
+1,80 %
Branche
Biotechnologie
Aktienmarkt
AMX
1-Jahres-Chart
PHARMING GROUP NV Chart 1 Jahr
5-Tage-Chart
PHARMING GROUP NV 5-Tage-Chart
RealtimeGeldBriefZeit
1,0001,01917:03
1,0001,01514.05.

Aktuelle News zur PHARMING Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoPharming Group N.V. - 6-K, Report of foreign issuer3
DoPharming Group reports financial results for the first quarter of 2021233Results impacted by effects of COVID-19 in the US; recovery towards the end of Q1 2021 with expected return to growth in Q2 2021 LEIDEN, Netherlands, May 13, 2021 /PRNewswire/ -- Pharming...
► Artikel lesen
22.04.Pharming Group N.V. - 6-K, Report of foreign issuer4
PHARMING Aktie jetzt für 0€ handeln
22.04.Pharming announces enrolment of first patient in multicentre Phase IIb clinical trial of RUCONEST for the prevention of acute kidney injury after myocardial infarction176Highlights: - Clinical trial follows encouraging results from a Phase II, which showed a statistically significant improvement of kidney injury biomarkers in patients undergoing coronary...
► Artikel lesen
07.04.Pharming Group N.V. - 20-F, Annual and transition report of foreign private issuers6
07.04.Pharming Group announces the filing of its 2020 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission263LEIDEN, Netherlands, April 7, 2021 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the filing of its Annual Report on...
► Artikel lesen
07.04.Pharming Group N.V. - 6-K, Report of foreign issuer2
06.04.Pharming Group announces the publication of its 2020 Annual Report and convenes its 2021 AGM267LEIDEN, The Netherlands, April 6, 2021 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces the publication of its Annual Report...
► Artikel lesen
23.03.Pharming Group N.V. - 6-K, Report of foreign issuer5
23.03.Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors341LEIDEN, Netherlands, March 23, 2021 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the intention to nominate Steven...
► Artikel lesen
16.03.Pharming Group to present at 31st Annual Oppenheimer Healthcare Conference229LEIDEN, Netherlands, March 16, 2021 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) today announces that its Chief Executive Officer...
► Artikel lesen
16.03.Pharming Group N.V. - 6-K, Report of foreign issuer4
11.03.Pharming Group N.V. - 6-K, Report of foreign issuer2
11.03.Pharming Group to Present at BioCapital Europe 2021247LEIDEN, The Netherlands, March 11, 2021 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announces that its Chief Executive...
► Artikel lesen
04.03.Pharming Group reports financial results for full year 2020376LEIDEN, Netherlands, March 4, 2021 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) presents its preliminary (unaudited) financial...
► Artikel lesen
03.03.Pharming FAQ: Was Sie über Fake-Webseiten wissen müssen9
02.03.Pharming Group N.V. - 6-K, Report of foreign issuer2
02.03.Pharming Group, in collaboration with Invitae Corporation, launches genetic testing program 'navigateAPDS' in US and Canada395- New program expected to improve access to genetic testing for activated PI3K delta syndrome (APDS), an ultra-rare immunodeficiency disease - Program has potential to advance clinical...
► Artikel lesen
23.12.20Pharming Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq Listed ADSs416Costs for conversion of Ordinary Shares into ADS's waived by JP Morgan Chase for initial four weeks after today LEIDEN, Netherlands, Dec. 22, 2020 /PRNewswire/ -- Pharming Group...
► Artikel lesen
23.12.20Pharming Group announces ADSs admitted to trade on Nasdaq under the symbol "PHAR"396U.S. SEC declares registration statements effective Each ADS represents 10 ordinary shares The Company's ordinary shares continue to trade on Euronext Amsterdam No new shares...
► Artikel lesen
Seite:  Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
41,1,3